Vimarsana
Biggest News Aggregation in the World

Nk Cell News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nk Cell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nk Cell Today - Breaking & Trending Today

MesoPher as a Maintenance Treatment after Chemotherapy, - Vimarsana News

MesoPher as a Maintenance Treatment after Chemotherapy,

Dublin, Nov. 23, 2023 (GLOBE NEWSWIRE) -- The

Innate Pharma Announces Abstracts Selected for ESMO Congress 2023 - Vimarsana News

Innate Pharma Announces Abstracts Selected for ESMO Congress 2023

MARSEILLE, France, October 16, 2023--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced that the following presentations will be presented at the European Society for Medical Oncology (ESMO) Congress 2023, taking place October 20-24 in Madrid, Spain.

Source: yahoo.com
Ozempic, Wegovy could boost cancer-killing cells, small study suggests - Vimarsana News

Ozempic, Wegovy could boost cancer-killing cells, small study suggests

A study of 20 people with obesity hinted at the possibility for semaglutide — the active ingredient in Type 2 diabetes drug Ozempic and weight-loss drug Wegovy — to increase the functionality of natural killer cells, which destroy cancerous cells. 

LevitasBio Launches LeviSelect Suite of Cell Depletion & Enrichment Kits - Vimarsana News

LevitasBio Launches LeviSelect Suite of Cell Depletion & Enrichment Kits

LevitasBio, Inc. (www.levitasbio.com), a premier end-to-end sample processing and cellular analysis provider to the life sciences market, unveils a suite of LeviSelect™ cell depletion and enrichment kits for immunology research.

Cellular Immunotherapy (CAR T Cell Therapy, Dendritic Cell - Vimarsana News

Cellular Immunotherapy (CAR T Cell Therapy, Dendritic Cell

Dublin, Jan. 06, 2023 (GLOBE NEWSWIRE) -- The "Global Cellular Immunotherapy Market Size, Share & Trends Analysis Report by Therapy Type (CAR T Cell...